Intravenous Gammaglobulin Inhibits Encephalitogenic Potential of Pathogenic T Cells and Interferes with their Trafficking to the Central Nervous System, Implicating Sphingosine-1 Phosphate Receptor 1–Mammalian Target of Rapamycin Axis-Reference-Cited by-同舟云学术

Intravenous Gammaglobulin Inhibits Encephalitogenic Potential of Pathogenic T Cells and Interferes with their Trafficking to the Central Nervous System, Implicating Sphingosine-1 Phosphate Receptor 1–Mammalian Target of Rapamycin Axis

Published:2013-03-22 Issue:9 Volume:190 Page:4535-4541
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Othy Shivashankar,Hegde Pushpa,Topçu Selma,Sharma Meenu,Maddur Mohan S.,Lacroix-Desmazes Sebastien,Bayry Jagadeesh,Kaveri Srini V.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Differentiation of Effector CD4 T Cell Populations

2. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation

3. IL-17 and Th17 Cells

4. Interleukin-17 and Type 17 Helper T Cells

5. FOXP3+ regulatory T cells in the human immune system

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism underlying polyvalent IgG-induced regulatory T cell activation and its clinical application: Anti-idiotypic regulatory T cell theory for immune tolerance;Frontiers in Immunology;2023-11-29

2. Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions;The Journal of Allergy and Clinical Immunology: In Practice;2023-06

3. Aging impairs arterial compliance via Klotho-mediated downregulation of B-cell population and IgG levels;Cellular and Molecular Life Sciences;2022-08-24

4. Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series;Dermatology;2022-08-23

5. Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis;Autoimmunity Reviews;2022-03